How to manage hot flashes in prostate cancer?
Baum
Neil
N
Tulane Medical School, New Orleans, USA.
D000284:Administration, Oral; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D001533:Belladonna Alkaloids / Q000008:administration & dosage; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004879:Ergotamines / Q000008:administration & dosage; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D019584:Hot Flashes / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D019290:Megestrol Acetate / Q000008:administration & dosage; D008784:Methysergide / Q000008:administration & dosage; D008875:Middle Aged; D010634:Phenobarbital / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D001533:Belladonna Alkaloids; D004338:Drug Combinations; D004879:Ergotamines; C044435:belladonna alkaloid, ergotamine, phenobarbital drug combination; D007987:Gonadotropin-Releasing Hormone; D004054:Diethylstilbestrol; C004955:fosfestrol; D017258:Medroxyprogesterone Acetate; D019290:Megestrol Acetate; D008784:Methysergide; D010634:Phenobarbital